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To test the feasibility of a randomized controlled study design comparing epidural analgesia
(EDA) with continuous wound infiltration (CWI) in respect to postoperative complications
and mobility to design a future multicentre randomized controlled trial.
Design, setting, participants
CWI has been developed to address drawbacks of EDA. Previous studies have established
the equivalent analgesic potential of CWI compared to EDA. This is a single centre, non-
blinded pilot randomized controlled trial at a tertiary surgical centre. Patients undergoing
elective non-colorectal surgery via a midline laparotomy were randomized to EDA or CWI.
Endpoints included recruitment, feasibility of assessing postoperative mobility with a
pedometer and morbidity. No primary endpoint was defined and all analyses were
explorative.
Interventions
CWI with local anaesthetics (experimental group) vs. thoracic EDA (control).
Results
Of 846 patients screened within 14 months, 71 were randomized and 62 (31 per group)
included in the intention-to-treat analysis. Mobility was assessed in 44 of 62 patients and
revealed no differences within the first 3 postoperative days. Overall morbidity did not differ
between the two groups (measured via the comprehensive complication index). Median
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pain scores at rest were comparable between the two groups, while EDA was superior in
pain treatment during movement on the first, but not on the second and third postoperative
day. Duration of preoperative induction of anaesthesia was shorter with CWI than with EDA.
Of 17 serious adverse events, 3 were potentially related to EDA, while none was related to
CWI.
Conclusion
This trial confirmed the feasibility of a randomized trial design to compare CWI and EDA
regarding morbidity. Improvements in the education and training of team members are nec-




Sufficient analgesia is a prerequisite for the successful perioperative management of patients
undergoing surgery and reduces postoperative complications and the development of chronic
pain [1,2]. In major abdominal surgery, different analgesic techniques such as systemic intra-
venous patient-controlled analgesia (PCA) or regional techniques, such as epidural analgesia
(EDA), are established standard procedures for effective perioperative pain control [3,4]. How-
ever, the ideal analgesic technique in abdominal surgery remains unclear and further RCTs are
needed [4]. More recently new locoregional analgesic techniques like continuous wound infil-
tration (CWI), in which a local anaesthetic is continuously applied into the laparotomy wound
via an elastomer pump, have been developed as potential alternatives to address drawbacks of
EDA and PCA [5].
Specifically, EDA has been criticised for causing rare, but serious adverse events, its multi-
ple contraindications, high failure rates [6], associated high personal and material costs [7] and
the associated immobilization patients due to equipment and urinary catheters [4]. Despite
these disadvantages, EDA compares favourably to systematic opioid use in some surgical spe-
cialties and for high risk patients [8–11]. A number of additional advantages like enhanced
pain control, reduced consumption of anaesthetics, reduction of the surgical stress response
and early bowel recovery have been postulated for EDA, however overall evidence is sparse
[4,12]. Furthermore, depending on trial design, study population, and comparators the effect
of EDA on clinically relevant outcomes such as morbidity and mortality are heterogeneous
[4,13,14].
CWI could potentially circumvent EDA-associated problems as placement into the laparot-
omy wound is fast and simple and the technique does not carry the risk of potentially detri-
mental epidural hematoma or infection. Also, CWI has already been shown to successfully
treat postoperative pain and a number of trials have established the equivalent analgesic poten-
tial of CWI vs. EDA following abdominal surgery [5,15].
Until now, however, no study has compared the overall postoperative morbidity of CWI
versus EDA directly. This is important, as postoperative morbidity and mortality in conjunc-
tion with pain control are arguably the most patient-relevant outcomes. Also, the widespread
implementation of EDA has been justified by its supporters because of its potential beneficial
PLOS ONE Continuous wound infiltration versus epidural analgesia for midline abdominal incisions
PLOS ONE | https://doi.org/10.1371/journal.pone.0229898 March 6, 2020 2 / 16
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
effect on postoperative recovery and pain [16]. Therefore, superiority in terms of postoperative
complications in conjunction with sufficient (non-inferior) pain control, could establish CWI
as a therapeutic alternative for patients undergoing major abdominal surgery.
Therefore, our current study was designed as a randomized-controlled pilot trial (RCT)
comparing EDA vs. CWI in patients undergoing major upper gastrointestinal surgery with the
focus on assessing feasibility of recruitment and feasibility of assessing postoperative patient
mobility via a pedometer Immobility has been associated with adverse outcomes like pulmo-
nary and thrombotic complications and is discouraged in all current enhanced recovery from
surgery (ERAS) guidelines [17]. Therefore, the objective unbiased assessment of postoperative
mobility is an important aspect of future RCTs. Finally, we aimed to raise preliminary data on
postoperative complications and pain to plan and conduct a future large multicentre RCT.
Methods
The Painless-Pilot trial was a randomized, controlled, non-blinded, single centre pilot trial
with two parallel study groups performed at the Department of General, Visceral and Trans-
plantation Surgery at Heidelberg University Hospital. The trial was performed according to
the IDEAL recommendations (step 2b exploration) [18] and the results are reported according
to current CONSORT guidelines with the extension for pilot and feasibility trials [19] (see S1
Checklist). In accordance with the professional code for physicians in Germany (§15 BOA¨),
the study protocol has been approved by the local independent ethics committee of the medi-
cal faculty of the University of Heidelberg (S-231/2015) on 11th August 2015 and was con-
ducted in accordance with the Declaration of Helsinki in its current version. It was registered
at the German Clinical Trials Register (DRKS00008023) and no changes to the methods or the
design of the study occurred after registration. Registration of the study was applied for in
April 2015. All queries from the DRKS were answered until the 31st August 2015 except the
planned inclusion date of the first patient (first-patient-in), which was correct in the DRKS
registry on 1st December 2015. Confirmation of registration occurred on 4th December 2015.
The first patient was recruited and randomized into the study on 20th October 2015. Until 4th
December 2015 eight patients were randomized into the trial. The authors confirm that all
ongoing and related trials for this drug/intervention are registered.
Inclusion/exclusion criteria
All patients aged 18 years or more scheduled for elective upper abdominal surgery (including
upper gastrointestinal, pancreatic, hepatobiliary, vascular and other surgery) via a midline lap-
arotomy with an indication for EDA were screened for eligibility. Rectal surgeries were
excluded, because of the frequent need for stoma placement, which creates an abdominal inci-
sion not reached by the CWI catheter. Furthermore, patients with chronic pain and/or regular
consumption of opioid analgesics were excluded due to potential confounding. Patients unable
to walk unaided were not admitted as postoperative mobility could not be evaluated in these
patients. Further exclusion criteria were a contraindication for EDA or CWI, planned stoma
placement, pregnancy or breast-feeding and participation in another interventional trial with
interference with the intervention or endpoint of this trial. Only patients able to understand
the character and all relevant aspects of the trial including aims, methods, risks and individual
consequences of this trial who provided written informed consent were included.
Randomisation and blinding
In order to achieve comparable intervention groups for known and unknown risk factors,
patients were allocated randomly to the two treatment groups using randomizer.at, a web-
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based tool from university Graz (Randomizer, Medical University of Graz, Institute for Medi-
cal Informatics, Statistics and Documentation (IMI)). A block-randomization with a block
length of four was implemented. Randomization was performed block wise (permuted blocks)
the day before or at the day of surgery at the Study Centre of the Department of General, Vis-
ceral, and Transplantation Surgery by the responsible study nurse. Blinding of patients, anaes-
thesiologists and outcome assessors to the intervention was not implemented as the insertion
of the epidural catheter is performed when the patient is awake. Moreover, the difference
between CWI and EDA will be obvious to patients and observers postoperatively. Given the
pilot aspect of this trial and the objective nature of most endpoints a non-blinded design of the
trial seemed justifiable.
Trial intervention and control group
Patients in the intervention group received a CWI catheter, which was placed suprafascially in
the surgical site of the midline laparotomy at the end of surgery after closure of the abdominal
fascia and before closure of the subcutaneous tissue and skin. The catheter covered the com-
plete length of the incision (S1 and S2 Figs). If necessary, more than one catheter was used. A
CWI catheter (On-Q1 PainBuster1, B.Braun, Melsungen, Germany) with Ropivacain 0.2%
isobar at 5ml/h for 3 days connected to an elastomeric pump continuously releasing the local
anaesthetic was used.
In the control group patients received a thoracic EDA (Perifix1Komplett, Fa. B.Braun
Melsungen) during preoperative induction of anaesthesia at Th 7/8 for upper GI procedures
and hepatobiliary surgery or Th 8/9 for pancreatic surgery according to internal standard
operating procedures. The catheter was inserted 5–6 cm into the epidural space. 5 mL Lidocain
2% were injected as a testing dose to exclude intrathecal placement. Before surgical incision,
10mL Ropivacaine 0.5% supplemented with 4mL Sufenta (R) epidural (20μg sufentanil) were
injected as a loading dose to facilitate epidural analgesia. To maintain epidural analgesia dur-
ing surgery a continuous infusion of 8 mL/h 0.2% Ropivacain was established until skin clo-
sure. In the postoperative period EDA was achieved with ropivacain 0.2% with sufentanil at 6-
10ml/h administered for 3 days according to the following scheme: on postoperative day 1
0.5μg/ml were administered, on day 2 the sufentanil dose was reduced to 0.25μg/ml. From day
3 on 0.2% ropivacaine was given without additional sufentanil.
All patients were seen by a dedicated acute pain service on a daily basis. A physician and a
pain nurse evaluate the puncture side for signs of infection or catheter dislocation. During
every visit pain level at rest and during movement were assessed and cold sensations were
tested to confirm sufficient pain control. In addition, all patients were screened for neurologic
deficits including assessment of muscle tone and strength.
Perioperative standards
Abdominal wound closure was performed in a standardized manner in small-stitches tech-
nique29 via a running suture with Monomax1 (Fa. B. Braun Melsungen, Germany). No sub-
cutaneous drains were placed in both groups with the exception of the CWI in the
intervention group. Overall postoperative management was performed identically in both
intervention groups according to hospital standard.
Both, CWI and EDA catheters were set to be removed at the third postoperative day. In
both groups, patients received a standardized additional pain medication with fixed-dose 1g
metamizole four times daily, and intravenous oxycodone 5mg up every 4 hours on demand. In
case of treatment failure defined as uncontrollable pain with a numeric rating scale of�5
despite the above-mentioned treatment regime a systemic oxycodon (1 mG/mL) PCA with no
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baseline rate, 1.5 mG oxcycodon bolus given over 3 minutes and a 20-minute hold-off period
was initiated. Other analgesic medication was not routinely given.
Outcome measures and assessment
The outcome assessors were study nurses and physicians of the clinical study center of the
Department of Surgery. Pain was evaluated by our interprofessional acute-pain team. All out-
come assessors were independent of the research team and were well trained before the start of
the study. The following postoperative outcome measures were assessed and no changes to the
outcome measures occurred after commencement of the trial:
A. Trial feasibility outcome measures
1. Accomplished recruitment of n = 70 patients within 6 months
2. Feasibility of assessing the postoperative mobility of patients via a digital pedometer
(OMRON Walking style Pro 2.0, OMRON Medizintechnik Handelsgesellschaft mbH
Mannheim, Germany) placed at patients’ right hip bone using adhesive bandage at the
end of surgery in at least two thirds of all patients. During the first three postoperative
days distance (in meters) and the number of steps were measured.
B. Analgesia-associated outcome measures
3. Pain scores at rest and during movement recorded on postoperative day 1–3 via a
numeric rating scale (NRS).
4. Amount of systemic opioid consumption in both groups within the first 3 postoperative
days in morphine equivalents. In order to compare different opioids, the following rules
were applied: a.) 1 mg oxycodone i.v. equals 1.3 mg morphine i.v., b.) 1 mg oxycodone
oral equals 0.5mg morphine i.v., c.) For the conversion of epidural opioids to i.v. opioids
we assumed that 1 mg epidural sufentanil equals 1 mg sufentanil i.v. which in turn equals
0.001 mg morphine i.v. based on the studies by Miguel et al. [20] and Taverne et al. [21].
Calculation of opioid consumption in EDA is controversial and some authors have dem-
onstrated a clinical advantage of epidural infusion over i.v. infusion with lower doses
needed via epidural application [22]. However, the latter effect is not relevant after the
first few postoperative hours [20,22]. For continuous EPA (�48 hours) as used in our
study conversion of epidural doses to i.v. doses in a 1:1 ratio seems justified [23].
5. Treatment-failure rate defined as uncontrollable pain with a numeric rating scale of�5
despite the randomized treatment regime with the need for an i.v. PCA (see above).
6. Duration of EDA /CWI therapy (in days).
7. Length of preoperative induction of anaesthesia and length of surgery (in minutes).
8. Length of hospital stay (in days)
9. Time to first flatus/bowel movement.
C. Morbidity endpoints
10. The overall postoperative morbidity of patients in the study was evaluated based on the
comprehensive complication index (CCI) [24,25].
D. Safety parameters
11. Frequency and severity of serious adverse events (SAE).
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12. Rate of catheter-related complications in both groups. In the EDA group the rate of cathe-
ter infections, dislodgement, neuroaxial hematoma, bleeding into the vertebral canal con-
firmed by MRI and/or CT scan was assessed. In the CWI group, the rate of surgical side
infection (SSI) according to the definition of the Centre for Disease Control and Preven-
tion was applied [26].
Description of trial visits
Demographic and baseline data were documented during visit 1. Patients were randomized
the day before or at the day of surgery (visit 2). Intraoperative parameters were recorded dur-
ing visit 2. Patients were planned for clinical follow-up at postoperative day 1, 2, 3, 7 and 30–
35 (visit 3–7) for evaluation of postoperative outcome measures and SAEs. Items assessed dur-
ing visits are listed in Table 1.
Statistical analyses
No formal sample size calculation was performed as this was a pilot trial. However, 60 patients
(30 patients in each group) were deemed necessary to draw valid conclusions about recruit-
ment rates, to achieve preliminary pedometer data and to confirm an expected median CCI of
approximately 20 in our mixed patient cohort, as has been reported previously in patients
undergoing pancreaticoduodenectomy (20.9 (0–29.6)) [25,27]. Following randomization, a
dropout rate of 10 patients (5 in each study arm) was expected leading to an overall recruit-
ment number of 70 patients.
As this was a pilot trial without confirmative character, no primary endpoint was defined
and all analyses were strictly explorative. We describe our data as median values along with
minimum and maximum values for ordinal or continuous, and relative and absolute frequen-
cies for categorical endpoints, stratified for treatment groups. We used nonparametric estima-
tion methods as the outcomes are either ordinal distributed or, in case of continuous
outcomes, because our pilot trial has a small sample size and normality cannot be assumed.
We further report Wilcoxon-Mann-Whitney odds (WMWodds) and their confidence
Table 1. Trial visits and documented parameters of the PAINLESS Pilot trial.
Visit 1 2 3–5 6–7
Screening/Consent Randomization/Intervention Post-op day 1,2,3 Post-op day 7 and 30–35
Inclusion/exclusion criteria X
Informed consent X




Number of steps/distance covered X
Pain scores (NRS) X
Time to first flatus/bowel movement X X
Body weight X X
Postoperative complications X X
Length of hospital stay X
SAEs X X
NRS: numeric rating scale. SAE: severe adverse event.
https://doi.org/10.1371/journal.pone.0229898.t001
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intervals as discussed by Franklin Dexter as an effect estimator [28]. All analyses were done
using SAS version 9.4.
Patient and public involvement
Patients and the public were not involved in the development of the protocol.
Results
Recruitment
All consecutive patients planned to undergo surgery at the department of General, Visceral and
Transplantation Surgery at Heidelberg University Hospital were screened for eligibility.
Between Oct 20th, 2015 to Dec 15th, 2016 (14 months) 846 patients were screened for eligibility
of which 71 patients were randomly assigned to CWI (n = 36) or EDA (n = 35) (Fig 1). A total
of 9 patients had to be excluded from the pilot trial after randomization either because no
median laparotomy was performed (L-incision (n = 2), laparoscopy (n = 4)) or no analgesia via
CWI or EDA was indicated because of short operation time (n = 1) or informed consent was
withdrawn (n = 2). These patients spread among the two groups as presented in S2 Table. From
these patients no data on visits after the surgical procedure was acquired and in particular, no
pedometer data was sampled for analysis. Thus, the population of this pilot trial consisted of 71
patients, out of which outcomes could be measured for 62 patients (31 patients in each group).
Patient characteristics
Baseline characters revealed no difference between the two study groups (Table 2). More
males (68.3%) than females were included in the study with an average age of 61.6 +/-12.4
Fig 1. CONSORT flow-chart.
https://doi.org/10.1371/journal.pone.0229898.g001
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years. Most patients had mild or severe systemic comorbidities indicated by the American
Society of Anesthesiologists physical status classification (ASA score) II (66.1%) and III
(32.3%). More specifically, 17.7% of trial participants had cardiac and 22.6% had pulmonary
comorbidities. The most frequent indications for surgery were pancreatic (56.5%) and upper
gastrointestinal diseases (22.6%). One patient planned for upper abdominal surgery, eventually
received colorectal surgery, but was not excluded from the ITT analysis.
Trial feasibility outcome measures
As pointed out above, 14 months were required to include the planned number of 70 patients
(5 patients/ month). Thus, our goal of recruiting 70 patients in 6 months (11.7 patients/
month) was not met. However, the second feasibility parameter (measurement of postopera-
tive mobilization via a pedometer in� 2/3 of patients) was successfully accomplished as 44
patients out of 62 in the ITT group received pedometers and data read-out. Reasons for failure
were (n = 4 pedometer lost, n = 7 unsuccessful data recording, n = 7 no pedometer attached
after surgery). Steps and distance covered by patients in the first postoperative days did not dif-
fer between groups in explorative analysis (Table 3). Number of steps increased daily from the
first postoperative day until the third postoperative day in both groups (Table 3).
Table 2. Baseline characteristics.
EDA CWI Total
N = 31 N = 31 N = 62
Gender
• male 21 (67.7%) 21 (67.7%) 42 (67.7%)
• female 10 (32.3%) 10 (32.3%) 20 (32.3%)
Age [years] Mean +/- SD 61.6 +/-13.6 61.6 +/-11.4 61.6 +/-12.4
BMI [kg/m2] Mean +/- SD 25.6 +/-5.3 25.6 +/-4.1 25.6 +/-4.7
ASA status
• I 1 (3.2%) 0 (0.0%) 1 (1.6%)
• II 21 (67.7%) 20 (64.5%) 41 (66.1%)
• III 9 (29.0%) 11 (35.5%) 20 (32.3%)
Underlying disease
• colorectal 0 (0.0%) 1 (3.2%) 1 (1.6%)
• hepatobiliary 0 (0.0%) 1 (3.2%) 1 (1.6%)
• pancreatic 20 (64.5%) 15 (48.4%) 35 (56.5%)
• upper GI 7 (22.6%) 7 (22.6%) 14 (22.6%)
• other 2 (6.5%) 4 (12.9%) 6 (9.7%)
Cardiac comorbidity 5 (16.1%) 6 (19.4%) 11 (17.7%)
Pulmonary comorbidity 7 (22.6%) 7 (22.6%) 14 (22.6%)
Type of surgery
• colorectal 0 (0%) 1 (3.2%) 1 (1.6%)
• upper gastrointestinal surgery 4 (12.9%) 5 (16.1%) 9 (14.5%)
• pancreatic surgery 17 (54.8%) 13 (41.9%) 30 (48.4%)
• hepatobiliary surgery 1 (3.2%) 1 (3.2%) 2 (3.2%)
• multivisceral resection 2 (6.5%) 3 (9.7%) 5 (8.1%)
• vascular surgery 2 (6.5%) 3 (9.7%) 5 (8.1%)
• other abdominal surgery 2 (6.5%) 1 (3.2%) 3 (4.8%)
• explorative laparotomy 3 (9.7%) 4 (12.9%) 7 (11.3%)
Insertion of surgical drains 24 (77.4%) 24 (77.4%) 48 (77.4%)
https://doi.org/10.1371/journal.pone.0229898.t002
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Analgesia-associated outcome measures
Explorative analysis of median pain scores at rest during the first three postoperative days
according to the NRS revealed no differences between the two groups (Table 3). Median (min;
max) pain scores during movement were lower with EDA than with CWI only on the first
postoperative day, but were not different on postoperative days two or three (Table 3).
The total amount of opioid consumption (including epidural sufentanil application in mor-
phine equivalents) within the first three postoperative days was lower on exploratory analysis
in the CWI group than in the EDA group who received a continuous infusion of ropivacaine
plus sufentanil (median(min; max) EDA: 216 (15; 429) mg vs. CWI: 102 (0; 318) mg; Wil-
coxon-Mann-Whitney odds (WMWodds): 3.35 CI [1.85; 8.19]).
Treatment failure, defined as uncontrollable pain despite the randomized treatment regime
with a numeric rating scale of�5 with the need of instalment of an i.v. PCA, occurred in 3
patients in the EDA group and 4 patients in the CWI group. Additional PCAs could be imple-
mented on the discretion of the treating physician. Therefore, the total number of PCA place-
ments was high in both groups: seven out of 31 patients in the EDA group received a PCA
(23%). Reasons were pain (n = 3), failure of EDA insertion (n = 3) or catheter dislocation
(n = 1). Out of 31 patients in the CWI group, 22 received an i.v. PCA (71%) because of pain
(n = 8), leakage of local anaesthetic from the wound (n = 1), failed CWI insertion (n = 2) or fol-
lowing relaparotomy (n = 1). An additional 10 patients received a “prophylactic” PCA in the
recovery room on the day of surgery, when recovery room physicians not acquainted with the
study protocol, assumed potential future inadequate pain control by the CWI, despite patients
reporting adequate pain scores in the recovery room with CWI alone.
Explorative analysis revealed that pain-catheter therapy was significantly longer with EDA
than with CWI median (min; max) EDA: 4 (0; 9) days versus CWI: 2 (0; 5) days, WMWodds:
2.95 [1.57;7.46]). Catheters were removed prematurely (before postoperative day 3 (POD)) in
11 and 4 cases in the CWI and EDA group, respectively.
Table 3. Postoperative outcomes (median minimum;maximum) and Wilcoxon-Mann-Whitney odds along with their confidence intervals.
EDA (n = 31) CWI (n = 31) WMW odds [lower; upper]
Pain scores at rest (NRS)
• POD 1 1.0 +/-1.3 1.2 +/-1.5 1.14 [0.64; 2.07]
• POD 2 0.7 +/-1.1 1.0 +/-1.5 1.25 [0.74; 2.19]
• POD 3 0.4 +/-0.8 0.7 +/-1.3 1.32 [0.83; 2.16]
Pain scores at movement (NRS)
• POD 1 2.7 +/-1.9 4.4 +/-2.3 2.53 [1.41; 5.59]
• POD 2 2.6 +/-1.8 3.1 +/-2.5 1.20 [0.67; 2.22]
• POD 3 1.6 +/-1.7 1.7 +/-1.7 1.06 [0.59; 1.89]
Duration of induction of anaesthesia (in min.) 59.8 +/-13.4 42.9 +/-11.3 5.08 [2.77; 14.66]
Duration of surgery (in min.) 218.6 +/-92.8 238.8 +/-116.5 1.30 [0.66; 2.25]
Duration of catheter therapy (in days) 3.6 +/-2.4 1.8 +/-1.3 2.95 [1.57; 7.46]
Time to first bowel movement (in days) 2.6 +/-0.8 2.8 +/-1.0 1.14 [0.66; 1.99]
Comprehensive complication index 21.5 +/- 16.2 18.2 +/- 15.2 1.31 [0.73; 2.47]
Number of steps POD 1 to POD 3 979.4+/-1489.7 874.5 +/-1574.5 1.43 [0.71; 3.20]
Length of hospital stay (in days) 11.0 +/-7.6 9.6 +/-4.7 1.10 [0.60; 2.02]
CCI: comprehensive complication index. CWI: continuous wound infiltration. EDA: epidural analgesia. NRS: numeric rating scale. POD: postoperative day. WMW
odds: Wilcoxon-Mann-Whitney odds
https://doi.org/10.1371/journal.pone.0229898.t003
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Duration of preoperative induction of anaesthesia was shorter (about 17 minutes) with
CWI compared to EDA, which were placed during induction of anaesthesia (Table 3). How-
ever, median (min;max) duration of surgery did not differ between the two groups (Table 3),
although CWIs were placed during surgery, directly after closure of the fascia. Similarly, dura-
tion of hospital stay and time to first bowel movement did not differ between both groups
(Table 3).
Morbidity endpoints
Explorative analysis of the CCI revealed no difference between groups (EDA 21 (0; 60.8) versus
CWI 15 (0; 59) WMWodds: 1.31 [0.73; 2.47]) with an overall CCI of 19.8 +/-15.7 and single
scores between 0 and 60.8. Overall, 13 major complications (defined as Clavien Dindo >II)
occurred in 10 patients (EDA: 6, CWI: 7).
Safety analysis
Safety analyses in terms of SAEs did not show any difference between groups. Overall six
patients experienced 17 SAEs with overall ten SAEs in the EDA group and seven SAEs in the
CWI group. Three SAEs in patients with an EDA were classified as potentially related to the
intervention (fall due to hypotension with serious face injuries, urosepsis associated with pro-
longed indwelling urinary catheter use and transient neurologic deficit of the lower limb). No
SAE was associated with CWI use.
Regarding catheter-related complications, three patients in the EDA group suffered from
paraesthesia, one had focal motor deficits, one had a superficial hematoma at the puncture
side, one had pain at the puncture side after multiple punctures and one suffered from hypo-
tension. No catheter related complications were recorded for the CWI group. Only one super-
ficial surgical site infection occurred in the EDA group and none in the CWI group.
Discussion
The main objectives of our pilot study were to inform the decision whether or not to conduct a
confirmatory trial comparing EDA with CWI in a multicenter setting and to inform the design
of such a potential trial. To this end, 70 patients undergoing elective open upper gastrointesti-
nal surgery were randomly assigned to epidural analgesia (EDA) or continuous wound infiltra-
tion (CWI) in the Painless Pilot trial and underwent a broad set of exploratory outcome
assessments including trial feasibility-, safety-, morbidity and analgesia-associated endpoints.
Recruitment took longer than expected (14 months instead of 6 months). Postoperative mobil-
ity was successfully measured via pedometers and showed no difference between the two
groups on exploratory analysis. Similarly, morbidity assessment via the comprehensive com-
plication index, pain and safety assessment were successfully established in the study.
Valuable information can be drawn from the results of the PAINLESS Pilot trial for a multi-
centre RCT comparing EDA vs. CWI following upper gastrointestinal surgery, thus confirm-
ing the importance of pilot trials for the planning of high-quality trials in surgery [29]. While
the analgesic potential of CWI has been established to be comparable to EDA [5], no high-
quality study has yet compared the two methods in regard to their effect on postoperative mor-
bidity. While on one hand the overall results warrant a larger multicentre trial, on the other
hand we encountered several problems that would need to be addressed in future studies.
First, recruitment was difficult in our trial and only 71 out of 555 eligible patients were
eventually randomized during a 14-month period. This is less than has been reported in other
RCTs [5,15,30]. Reasons might partially reflect specificities of our centre as 156 patients were
excluded because of interfering trial participation. However, most patients (n = 312) declined
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to participate. In our trial patient recruitment was hampered in the multidisciplinary teams as
not all healthcare professionals were convinced of the clinical equipoise of the two interven-
tions with some favouring CWI and other EDA due to individual opinion. Hence, preopera-
tively patients repeatedly received diverging information resulting in a lack of informed
consent. As analgesia touches multiple stakeholders (patients, anaesthetists, surgeons, nurses,
pain teams etc) sufficient training and education of all team members seems vital for the suc-
cessful conduct of future studies.
Second, based on the preliminary data from our pilot trial a sample size of roughly 712
patients would be necessary to detect the observed mean difference of CCI between EDA and
CWI when applying a two-sided t-test with a power of 80% and chosen level of significance of
5% (two-Sample t-tests, calculated with PASS). Consequently, in a future multicenter trial 10
sites could recruit the necessary number of patients in around 15 months.
Third, lack of sufficient information and training likely explains two other problems we
encountered during our pilot study, namely the high rate of “prophylactic” PCA placements in
the recovery room in the CWI group and the loss of pedometers in about one third of patients.
“Prophylactic” placement occurred when recovery room physicians not acquainted with the
study protocol, assumed potential future inadequate pain control by the CWI, despite patients
reporting adequate pain scores in the recovery room with CWI alone. Similarly, pedometers
were frequently removed by nursing personnel not acquainted with the specifics of our study.
Pedometer bracelets, rather than attaching the pedometer to the patients’ hip with adhesive
tape, might circumvent this problem in future trials.
Fourth, as in previous trials CWI was not inferior to EDA in pain control on explorative
analysis [5] with exception of pain during movement on the first postoperative day. The latter
seems of minor clinical relevance, as a difference of less than two points on the numeric rating
scale is considered to be clinically irrelevant in pain research and salvage application of analge-
sia is easily possible. Similar to our results, a recent RCT comparing EDA vs. CWI in colorectal
surgery has reported only a transient superior analgesic effect of EDA on the first postoperative
day [31]. However, interpretation of pain data in our trial is hindered by the high rate of PCA
use in the EDA and especially the CWI group. The PCA rate in the EDA group was higher
than generally reported in the literature [32] and might be due to previous overestimation of
the reliability of the EDA [33,34] and might partially explain previous results that have shown
inadequate postoperative pain management [13]. Given that the total amount of opioid con-
sumption was lower in the CWI group, the high rate of PCA placement in the CWI group can-
not be explained by inadequate pain control. As pointed out above some PCAs were placed
prophylactically in the recovery room, an issue which could be addressed by improved training
of study personnel. Finally, gender differences between the two groups might account for dif-
ferences in pain perception [35] and future trials should therefore implement stratification
according to sex.
Fifth, several CWI catheters were also removed early (and PCA placed) because of leakage
of local anaesthetics from the wound. This problem was caused by the subcutaneous placement
of the catheter, the relatively high flow rate of the CWI in our study compared to previous trials
[5,15] and the lack of subcutaneous fat in cachectic tumour patients. Hence in future trials the
catheter position might be change to a preperitoneal position. At the time we planned our
trial, the optimal catheter position for CWIs in abdominal surgery was unclear and available
results indicated that the catheter position has no effect on analgesic effect [5]. In the mean-
time a meta-analysis indicates that preperitoneal catheter positions for CWI are superior to
subcutaneous positions in terms of pain control [15]. Thus, a preperitoneal position seems
warranted in future trials.
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Strength and limitations
Our pilot study established the feasibility of measuring the CCI [24,25] in a randomized trial
design comparing EDA and CWI. Our preliminary data confirms CCI scores in comparable
patient populations [25,36]. The CCI seems a suitable endpoint for comparing postoperative
complications as it catches the entirety of complications, rather than focusing on a single com-
plication as has been done in previous trials comparing analgesic techniques [8,37]. As the
CCI is based on the established Dindo-Clavien classification of complications, its evaluation is
objective and not influenced by an unblinded trial design. Finally, pedometers seem a promis-
ing tool for evaluating postoperative mobility. They allow a standardized and objective readout
and might circumvent problems associated with mobility scores or questionnaires. Early
mobilization is a crucial component of the enhanced recovery after surgery (ERAS) clinical
care protocol [17] and a fundamental for prophylaxis of deep vein thrombosis and pulmonary
embolism [38].
A limitation of our trial was the unblinded trial design. Blinding EDA and CWI procedures
would require significant efforts. EDA catheters are placed when the patient is awake making
blinding impractical. A potential way of blinding would be to place sham EDA or CWI cathe-
ters. However, this not only raises ethical concerns, but also contradicts the pragmatic nature
of the trial as it would create an artificial intervention with two catheters in each patient. Fur-
thermore, it is still unclear if such blinding measures really reduce performance and detection
bias [39]. Although we tried to compensate for a potential reporting bias by choosing objective
outcomes measures like the CCI or pedometer data, we cannot rule out detection bias for
more subjective outcome measures like pain.
Safety
It was crucial to establish that the CWI does not inflict any potential harm on patients.
Although postoperative overall morbidity in the CWI group evaluated via the CCI, SAEs, rate
of catheter related complications and surgical side infections were not different in the two
groups, the rate of SAEs in the EDA group was high. This is in line with recent reports that
have shed a more critical light on EDA-associated adverse events [13,40].
As expected, duration of induction of anaesthesia was shorter with CWI in our trial, which
is a relevant economic advantage for our health care system compared to EDA. This supports
recent studies that have outlined the high costs associated with EDA [7].
Conclusion
Our findings support the increasing recognition of CWI as a useful and safe technique within
a multimodal approach to postoperative pain management [15]. Based on results of our pilot
study, a large multicentre RCT comparing CWI and EDA in terms of postoperative complica-
tions, pain and mobility seems feasible. As indicated above, several modifications to the trial
design are necessary to address the problems identified in our pilot study.
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